6319-54-6Relevant articles and documents
Synthesis of new xanthene derivatives with expected antischistosomal activity
Zeid,El-Kousy,Moneim El-Torgoman,Hamid Ismail
, p. 163 - 164 (1987)
-
Electrochemical Decarboxylative N-Alkylation of Heterocycles
Baran, Phil. S.,He, Chi,Shang, Ming,Sheng, Tao,Vantourout, Julien. C.,Zhang, Hai-Jun
supporting information, p. 7594 - 7598 (2020/10/09)
An operationally simple method to employ nonactivated carboxylic acids as alkylating agents in the N-alkylation of heterocycles is reported through an electrochemically driven anodic decarboxylative process. A wide substrate scope across a range of heterocycles is demonstrated along with a series of applications that significantly reduce the step count required to access such medicinally relevant structures.
Gastric antisecretory 9H-xanthen-9-amines
Bender,Perchonock,Groves,Smith Jr.,Stringer,Sneed,Schlosser,Hostelley,Hwang,Eby,Konicki,Lavanchy,Wilson III,Loev
, p. 1218 - 1223 (2007/10/02)
A series of 9H-xanthen-9-amines possessing a wide variety of nitrogen substituents at C-9 was prepared for evaluation of gastric antisecretory activity. These substituents included the acetamidine, imidate, pyrimidine, thiazoline, quinuclidine, 2-hydrazinopyridine, aminopiperidine, aminoalkylimidazole, and aminoalkylpyridine moieties. The majority of compounds in this series inhibited gastric acid secretion when tested orally in the pylorus-ligated rat. Potency was increased by intraduodenal administration and diminished by incubation with gastric juice, suggesting partial degradation of the compounds in the gastric environment. A representative example, 3-(9H-xanthen-9-ylamino)-1-ethylpiperidine, exhibited similar activity in dogs, although no free compound could be detected in the blood. It is therefore hypothesized that this compound is either rapidly bound to tissue and/or metabolized to an active species.